Current molecular design of intelligent drugs and imaging probes targeting tumor-specific microenvironments

Kazuhito Tanabe1, Zhouen Zhang, Takeo Ito

  • 1Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University, Katsura Campus, Kyoto 615-8510, Japan.

Insights

This review explores intelligent, multi-functional molecular systems for advanced cancer therapy and diagnosis. It focuses on designing tumor-targeting drugs and imaging probes that exploit tumor microenvironments like angiogenesis and hypoxia.

Area of Science:

  • Oncology
  • Molecular Imaging
  • Drug Development

Background:

  • Cancer therapy and diagnosis face challenges requiring novel approaches.
  • Intelligent drugs and imaging probes offer potential solutions.
  • Multi-functional molecular systems are key to developing these agents.

Purpose of the Study:

  • To review the molecular design of tumor-targeting drugs and imaging probes.
  • To highlight strategies for targeting tumor-specific microenvironments.
  • To discuss applications in cancer therapy and diagnosis.

Main Methods:

  • Literature review of molecular design principles.
  • Analysis of multi-functional systems for drug delivery and imaging.
  • Focus on targeting tumor microenvironments (angiogenesis, hypoxia).

Main Results:

  • Intelligent drugs and probes leverage multi-functional molecular systems.
  • Targeting tumor-specific microenvironments like angiogenesis and hypoxia is crucial.
  • These agents show promise for improved cancer therapy and diagnosis.

Conclusions:

  • Molecular design is critical for developing effective tumor-targeting agents.
  • Exploiting tumor microenvironments enhances drug and probe specificity.
  • This approach advances cancer treatment and non-invasive molecular imaging.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.